Syra Health annual ebitda
2022
2023
2024
2025
Syra Health EBITDA Growth & History (SYRA)
Syra Health's calculated EBITDA was −$883,856 for fiscal 2025.
View full Syra Health company overviewSyra Health annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$883,856 | $2.8M | — |
| 2024 | 2024-12-31 | −$3.7M | −$863,319 | — |
| 2023 | 2023-12-31 | −$2.8M | −$763,982 | — |
| 2022 | 2022-12-31 | −$2.1M | — | — |
Syra Health quarterly ebitda
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $252,312 | $309,492 | — |
| Q1 2026 | 2026-03-31 | $192,037 | $658,574 | — |
| Q4 2025 | 2025-12-31 | −$133,364 | $361,026 | — |
| Q3 2025 | 2025-09-30 | −$226,775 | $176,594 | — |
| Q2 2025 | 2025-06-30 | −$57,180 | $1.3M | — |
| Q1 2025 | 2025-03-31 | −$466,537 | $964,872 | — |
| Q4 2024 | 2024-12-31 | −$494,390 | $479,406 | — |
| Q3 2024 | 2024-09-30 | −$403,369 | −$72,710 | — |
| Q2 2024 | 2024-06-30 | −$1.4M | −$601,318 | — |
| Q1 2024 | 2024-03-31 | −$1.4M | −$668,697 | — |
| Q4 2023 | 2023-12-31 | −$973,796 | — | — |
| Q3 2023 | 2023-09-30 | −$330,659 | $12,252 | — |
| Q2 2023 | 2023-06-30 | −$771,661 | — | — |
| Q1 2023 | 2023-03-31 | −$762,712 | — | — |
| Q3 2022 | 2022-09-30 | −$342,911 | — | — |
Syra Health ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Syra Health's ebitda increased from −$2.1M to −$883,856, a change of $1.2M. The latest reported quarter, Q2 2026, shows $252,312.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Syra Health source filings ↗